![]() |
![]() ![]() ![]() ![]() 0 items: $0.00 |
![]() |
Home | About Us | F.A.Q. | Account | Log In | Terms | Contact Us | ![]() |
*** This is a Pre-Order item ***
Pre-Order items require a minimum 10% deposit.
This item's selling price is $85.00
A charge of $10.00 is required when ordering this item. The balance due when this item is in stock will be $75.00 plus shipping.
Shipping will depend on the weight of this item boxed and will be added to the balance due once we calculate the final shipping weight.
If you have any questions on this preorder policy, you can refer to our preorder policy in our Terms section or you can send our customer service department an email at customerservice@fanboycollectibles.com or use the Contact Us form.
Mezco One:12 Collective Marvel Morbius Figure
“I'm not a man to play with bluffs... I mean what I say.”
The One:12 Collective welcomes Morbius, the living vampire!
Morbius wears a fitted bodysuit with a winged cape and features three head portraits, capturing varying degrees of his grisly nature.
The Nobel Prize-winning biochemist comes complete with a multilayer mobile science lab with a light-up function. The removable top layer holds science equipment such as a foldable microscope, handheld hematology analyzer, and removable test tube and beaker, while the bottom layer conceals weapons such as a dagger, customized handgun, and hammer.
While attempting an experimental treatment involving vampire bat DNA and electroshock therapy, Dr. Michael Morbius turns himself into a pseudo-vampire in an effort to cure his rare blood disease. As a result, he develops superhuman powers including enhanced agility, strength, and stamina. With an insatiable lust for human blood, the nightmarish vigilante finds himself torn between his human and monstrous natures.
The One:12 Collective Morbius Figure Features:
Each figure is packaged in a deluxe, collector friendly box, designed with collectors in mind there are no twist ties for easy in and out of package display.
This Figure is Due out in the 4th Quarter of 2021.